A CASE OF A CHRONIC LYMPHOPROLIFERATIVE DISORDER PRESENTING AS AUTOIMMUNE HEMOLYTIC ANEMIA

2021 ◽  
pp. 13-14
Author(s):  
Jessica Pereira ◽  
Aparna Pai

Lymphoproliferative disorders encompass a group of diseases with a highly variable clinical course. This is a case report of a patient who presented with haemolytic anemia initially and was subsequently diagnosed as a chronic lymphoproliferative disorder. He was treated with Rituximab to which he showed a favourable response.

2014 ◽  
Vol 25 (1) ◽  
Author(s):  
Hasan M. Isa ◽  
◽  
Lina F. Al Ali ◽  
Afaf M. Mohamed ◽  
Rawia M. Hamad ◽  
...  

2019 ◽  
Author(s):  
ANA GABRIELA CARDOSO FERRAZ ◽  
NARA LÍDIA FONSECA DE OLIVEIRA ◽  
YARA DE PAULA DUARTE LACERDA ◽  
ANA CAROLINA OLIVEIRA E SILVA MONTANDOM ◽  
NILZIO ANTÔNIO DA SILVA ◽  
...  

2014 ◽  
pp. 328-331
Author(s):  
Quan Le Zhang ◽  
Li Juan Jia ◽  
Jin Biao Zhang ◽  
Wei Min Li ◽  
Yuan Kai Bo ◽  
...  

1998 ◽  
Vol 5 (2_suppl) ◽  
pp. 51-53 ◽  
Author(s):  
Thomas P. Loughran

The onset of anemia in patients with lymphoproliferative disorders can be attributed to various causes, including autoimmune hemolytic anemia, pure red cell aplasia, and anemia of chronic disease. A variety of interventions can provide benefit.


2019 ◽  
Vol 12 ◽  
pp. 1179545X1989457
Author(s):  
Tahseen Hamamyh ◽  
Mohamed A Yassin

Autoimmune hemolytic anemia is one of the differential diagnoses for anemia in patients with lymphoproliferative neoplasia, such as chronic lymphocytic leukemia, who experience sudden drop in hemoglobin. The association between autoimmune hemolytic anemia and chronic myeloid leukemia on the contrary is unusual. Here we present a patient with a background of chronic myeloid leukemia treated previously with Tyrosine Kinase Inhibitors, then developed autoimmune hemolysis simultaneously with chronic myeloid leukemia relapse. Hemolysis was treated with steroids with good response.


Sign in / Sign up

Export Citation Format

Share Document